Click on a filter below to refine your search. Remove a filter to broaden your search.
However, physicians had substantially lower excess mortality than the general U.S. population.
The findings show a lower hospitalization risk 31 to 120 days after COVID-19 infection.
In New England and the Pacific, prevalence tended to be lower, whereas higher prevalence was seen in the South, Midwest and West.
Further, vaccinated people were at lower risk of long-term breathing difficulties than unvaccinated individuals.
The rate of hospitalization due to COVID-19 and death was reduced for treated versus untreated patients among those aged 65 years and older.
A reduced risk of hospitalization or death was seen at 28 days; a lower risk was seen for all individual mAb products.
The lower screening rates for cervical, breast and colorectal cancers suggest a “pattern of forgone care,” according to the researchers.
Mortality rates were lower for omicron BA.2 than for the delta variant and omicron B.1.1.529.
Adjusted hazard ratios for hospitalization and death were reduced with both treatments.
The rate of all-sites cancer incidence was 28.6% lower than expected during the height of the COVID-19 pandemic response.